Paxil Failure-To-Warn Claims are Not Preempted, Judge Rules



DOCUMENTS
  • Opinion and Order


OKLAHOMA CITY - Federal law does not preempt failure-to-warn claims brought against the manufacturer of Paxil because the drug maker provided no evidence that it tried to strengthen the label's warnings regarding pregnancy-related risks prior to September 2005, an Oklahoma federal judge has ruled. Hayes, et ux. v. GlaxoSmithKline, No. 07-0682 (N.D. Okla.).

On Dec. 14, Chief Judge Claire V. Eagan of the U.S. District Court for the Northern District of Oklahoma also denied GlaxoSmithKline's motion for summary judgment on plaintiffs' punitive damage claims, ruling that a jury could find that GSK "acted recklessly or with conscious disregard for the …






UPCOMING CONFERENCES




HarrisMartin's New Jersey Asbestos Litigation Conference

March 03, 2023 - New Brunswick, NJ
Hyatt Regency New Brunswick

MORE DETAILS



HarrisMartin's MDL Conference: Managing Mass Torts, Status of Key Litigations and Lessons Learned

March 29, 2023 - Tucson, AZ
Hotel Details in Tucson, Arizona, to be Announced

MORE DETAILS